What Pharma Tech Outlook does

Pharma Tech Outlook is a privately held B2B media and publishing company founded in 2008 and headquartered in Fort Lauderdale, Florida, operating with 11-50 employees. Its core product is a monthly magazine, distributed in both digital and print form, that covers pharmaceutical technology across sub-verticals such as Drug Discovery and Development, Pharma AI, Pharma Analytics, Pharma Manufacturing, eClinical Trial Management, Drug Delivery, Contract Research Organizations, and related areas. The technical footprint is a standard web-based content platform with digital magazine flipbook functionality and an email newsletter distribution system; no proprietary AI models, SDK, API, or patents are disclosed in the source data.

The company monetizes through three streams: recurring subscriptions to the magazine, advertising and sponsored content (including company profiles and leadership features) sold to pharmaceutical companies and technology vendors, and revenue from conferences and the CXO Awards program. Distribution spans three regional editions - US, Europe, and APAC - each with its own constellation of topic portals, supported by a Weekly Brief newsletter, LinkedIn and X/Twitter social channels, and live industry conferences. Founder and CEO Robert Baurys leads the firm; no management team, institutional investors, funding rounds, parent company, or ownership structure are disclosed in the provided data.

Customers and content contributors include named executives from Pfizer, Sanofi, Novartis, Agios Pharmaceuticals, BeiGene, Lonza, Novo Nordisk, Viatris, Mallinckrodt Pharmaceuticals, Otsuka Pharmaceutical, Kindeva Drug Delivery, Lantheus, and Virpax Pharmaceuticals, indicating engagement at the enterprise level across pharmaceutical, biotechnology, and medical device segments. Pricing is not publicly disclosed; subscription terms indicate annual cadence with quote-based pricing. Revenue, ARR, and headcount growth metrics are not provided in source material.

Name

Pharma Tech Outlook

Legal name

Pharma Tech Outlook

Website

https://pharmatechoutlook.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharma Tech Outlook is a privately held B2B media company founded in 2008 that publishes a monthly digital and print magazine, email newsletter, topic-specific portals, and CXO Awards covering pharmaceutical technology for pharma, biotech, and medical-device advertisers and readers across the US, Europe, and APAC.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Trade Media

NAICS

Marketing Consulting Services (541613)

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Pharmaceutical trade media
• Pharma technology publication
• Industry editorial coverage
• Pharma executive interviews
• Healthcare technology news

Headquarters

HQ city

Fort Lauderdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Marketing or Sales, Operations

Revenue model

1. Magazine Subscriptions: Subscription-based access to digital and print editions of the pharmaceutical technology magazine
2. Advertising: Revenue from pharmaceutical companies and technology vendors advertising in the magazine and on the website through display ads, sponsored content, and company profile features
3. Conference and Events: Revenue from pharmaceutical industry conferences and events including CXO Awards

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Pharma Tech Outlook is a trade publication delivering editorial coverage of pharmaceutical technology, including feature articles, executive interviews, and trend analysis aimed at pharma industry professionals. No source-backed description is available in the supplied input.

Product overview

Pharma Tech Outlook is a media and publishing company that provides a comprehensive platform for the pharmaceutical technology industry. The company publishes a digital and print magazine and maintains multiple topic-specific portals covering pharmaceutical sectors including Drug Discovery, Pharma AI, Pharma Analytics, Pharma Manufacturing, eClinical Trial Management, Drug Delivery, Contract Research Organization, and others. Its portfolio includes Leadership Perspectives (an industry leader forum), Innovation Insights, News coverage, CXO Awards recognition program, and an annual Conference. The company also publishes the Top AI Solution Providers for the Pharmaceutical Industry annual listing, recognizing leading AI solution providers evaluated by industry peers and experts.

Differentiator

Problem solved

Functional benefit

Brands

• CXO Awards: Awards program recognizing excellence in pharmaceutical technology leadership
• Leadership Perspectives
• Innovation Insights

Products and services

• Pharma Tech Outlook editorial publication Trade publication delivering editorial coverage of pharmaceutical technology for industry professionals. Source-backed details are not evidenced in the supplied input.

Named customers13 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor.

• Korea UniversityminorStrategic or Co-development PartnerAcademic collaboration combining technical AI tools with human expertise in drug discovery research
• Yeungnam UniversityminorStrategic or Co-development PartnerAcademic partnership supporting collaborative approach to drug discovery combining AI tools with domain expertise
• Baylor College of MedicineminorStrategic or Co-development PartnerResearch origin for CALICI company founding, where the team developed initial AI drug discovery concepts while working on antiviral treatments

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Drug Discovery World: A B2B publication and digital platform covering drug discovery and development technology. Comparable as a vertical trade publication with overlapping advertiser base in pharma R&D tools and services.
• Outsourced Pharma: A B2B media outlet focused on pharmaceutical outsourcing, CDMOs, CROs, and contract manufacturing. Comparable as a niche vertical pharma-tech publication with overlapping advertiser base in drug development services.

Regional players

• MedCity News: A B2B media outlet covering healthcare innovation, life sciences, and digital health. Comparable as a healthcare/life sciences B2B media brand monetized through advertising and events, with overlapping pharma tech advertiser base but broader healthcare coverage.

Direct peers

• Fierce Pharma: A leading pharmaceutical industry trade publication covering drug development, commercialization, and technology. Comparable as a B2B pharma media brand monetized through display advertising, sponsored content, and newsletters reaching pharma decision-makers.
• BioSpace: A B2B media and talent platform serving the biopharma and life sciences industry. Comparable in monetizing a vertical pharma audience through advertising, sponsored content, company profiles, and events targeted at pharma professionals.
• BioCentury: A subscription-based biopharmaceutical business intelligence and media company. Comparable as a high-value vertical media business monetizing through subscriptions, advertising, and proprietary analysis targeting pharma and biotech decision-makers.
• BioPharma Dive: A B2B media publication providing news, analysis, and insights for the biopharmaceutical industry. Directly comparable to Pharma Tech Outlook as a vertical-focused trade publication monetizing through advertising, events, and sponsorships targeting pharma executives.
• Endpoints News: An independent news outlet covering the biopharma industry with subscriptions and advertising revenue. Directly comparable in delivering pharma industry intelligence, leadership perspectives, and company coverage to pharma executives and investors.

Broad incumbents

• Pharmaceutical Executive (MJH Life Sciences): A print and digital publication covering business strategy, policy, and innovation in the pharmaceutical industry, owned by MJH Life Sciences. Comparable as a pharma industry trade publication monetized via advertising, subscriptions, and events.
• Pharmaceutical Technology (Informa): A long-established B2B trade publication covering pharmaceutical manufacturing, drug development, and regulatory topics, owned by Informa. Comparable as a pharma-tech-focused media brand with multi-channel content, events, and advertising — but with substantially larger scale and a broader portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/pharmaoutlook
• LinkedInlinkedin.com/company/pharmatechoutlook

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Tech Outlook